Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2001
11/28/2001EP1157008A1 Quinoline derivatives as tyrosine kinase inhibitors
11/28/2001EP1156803A1 LACTAM INHIBITORS OF FXa AND METHOD
11/28/2001CN1324357A 3-(substituted phenyl)-5-thienyl-1,2,4-triazole compounds with activity against whitefly
11/28/2001CN1324356A Process for preparing 3-(substituted phenyl)-5-thienyl or fully)-1,2,4-triazoles and nove. intermediates utilized therein
11/28/2001CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001CN1324250A Method for treating or preventing viral infections and associated diseases
11/28/2001CN1324212A Method for treating or preventing viral infections and associated diseases
11/28/2001CN1075497C Pyrazole-4-yl-heteroyl derivatives as herbicides
11/27/2001US6323235 Benzene-condensed heterocyclic derivatives and their uses
11/27/2001US6323228 3-substituted indole angiogenesis inhibitors
11/27/2001US6323227 Prodrugs
11/27/2001US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds
11/27/2001US6323215 Treat and prevent disorders characterized by neuronal damage such as parkinson's disease, alzheimer's disease, stroke, multiple sclerosis, amyotrophic lateral sclerosis, diabetic neuropathy and bell's palsy.
11/27/2001US6323212 Method for reducing pain, which comprises administering an effective analgesic amount of the morphinan derivative
11/27/2001US6323210 Transferase inhibitor
11/27/2001US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001CA2041835C Cyclohexenone oxime ethers, their preparation and their use as herbicides
11/22/2001WO2001087879A1 New thiochromane derivatives and their use as thrombin inhibitors
11/22/2001WO2001087877A1 Novel thiophenamide compounds
11/22/2001WO2001087870A1 Hydroxamic acid derivatives
11/22/2001WO2001087854A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001WO2001087845A2 N-containing heterocyclic compounds and their use as 5-ht antagonists
11/22/2001WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001WO2001087830A2 Substituted thioacetamides
11/22/2001WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001WO2001087826A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/22/2001WO2001087287A2 Use of pyrazole derivatives for treating infertility
11/22/2001WO2001025227A3 Quinolyl propyl piperidine derivatives and their use as antibacterial agents
11/22/2001WO2001005769A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/22/2001US20010044461 Selective dopamine D3 antagonists free from neurological side effects of conventional neuroleptics
11/22/2001US20010044445 Azole inhibitors of cytokine production
11/22/2001US20010044433 Specific antitumor activity against breast, colon, lung, prostate cancers and melanomas
11/22/2001CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001CA2409445A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/22/2001CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001CA2409116A1 Substituted thioacetamides
11/22/2001CA2409035A1 Hydroxamic acid derivatives
11/22/2001CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001CA2407222A1 New thiochromane derivatives and their use as thrombin inhibitors
11/22/2001CA2405507A1 Use of pyrazole derivatives for treating infertility
11/22/2001CA2375065A1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
11/21/2001EP1156045A1 Amide derivatives and drug compositions
11/21/2001EP1155010A1 Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
11/21/2001EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001EP1154992A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production
11/21/2001EP0917555B1 Electrochrome system
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001EP0900207B1 Pyrazinone thrombin inhibitors
11/21/2001EP0833827B1 2-amino-1,3,5-triazines, process for their preparation and their use as herbicides and plant-growth regulators
11/21/2001EP0831910B1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
11/21/2001EP0650480B1 1-arylsulphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
11/21/2001CN1323396A Endogenous constitutively activated G protein-coupled orphan receptors
11/21/2001CN1323304A 2-hetaryl-3,4-dihydro-2h-pyrrole derivatives
11/21/2001CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001CN1323297A Pyridazinone derivatives
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001CN1075071C (R)-(E)-(4-substituted phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylacetonitrile, antifungal composition containing the same and producing process thereof
11/21/2001CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
11/21/2001CN1075069C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes
11/21/2001CN1075066C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
11/21/2001CN1074926C Antiarrhythmic benzodiazepines
11/20/2001US6320051 Amino(nh) or oxygen(o) substituted, enzyme inhibitors of staphloccocus aureus methionyl t-rna synthetase (mrs); antibacterial agents
11/20/2001US6319939 Retinoic acid mimetic anlides
11/20/2001US6319428 Perfluorinated amide salts and their uses as ionic conducting materials
11/20/2001CA2046126C 2-thienylglycidic derivative, process for its preparation and its use as synthesis intermediate
11/20/2001CA2025599C Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
11/15/2001WO2001085722A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001WO2001085721A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23
11/15/2001WO2001085720A1 Novel anti-infectives
11/15/2001WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001WO2001085716A1 2-piperidone compounds for the treatment of cancer
11/15/2001WO2001085714A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001WO2001085701A1 5-ht7 receptor antagonists
11/15/2001WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001WO2001085693A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001WO2001017963A3 Aminoalkoxy carbazoles and their use as 5-ht ligands
11/15/2001WO2001014339A3 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
11/15/2001US20010041802 Glucocorticoid receptor antagonists for treatment of diabetes
11/15/2001US20010041714 Serotonin-7 (5-HT7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/15/2001US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001US20010041674 Reacting a acetophenyl derivative with an aromatic aldehyde or heterocylic containing aldehyde derivative by aldol condentation followed by reduction
11/15/2001CA2409729A1 5-ht7 receptor antagonists
11/15/2001CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001CA2408343A1 N-acyltetrahydroisoquinoline derivatives
11/15/2001CA2408156A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
11/15/2001CA2406634A1 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by the np y5 receptor
11/15/2001CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/14/2001EP1153924A2 Substituted 1,3-oxathiolanes with antiviral properties
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP1153022A1 Prothease inhibitors
11/14/2001EP1153013A2 5-ht1f agonists
11/14/2001EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001EP1021437B1 Arylsulfonylimidazolone derivatives as an antitumor agent
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 523